Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Annamycin

Annamycin

Annamycin structure

Annamycin 

structure
  • CAS No:

    92689-49-1

  • Formula:

    C26H25IO11

  • Chemical Name:

    Annamycin

  • Synonyms:

    5,12-Naphthacenedione,7-[(2,6-dideoxy-2-iodo-α-L-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-,(7S,9S)-;5,12-Naphthacenedione,7-[(2,6-dideoxy-2-iodo-α-L-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-,(7S,9S)-;(7S,9S)-7-[(2,6-Dideoxy-2-iodo-α-L-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-5,12-naphthacenedione;Annamycin;1195300-26-5

  • Categories:

    Biochemical Engineering  >  Saccharides

Description

Annamycin is a lipophilic, anthracycline antineoplastic antibiotic. Annamycin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and repair as well as inhibiting RNA and protein synthesis. This agent appears to not be a substrate for the p-glycoprotein associated multidrug-resistance (MDR) transporter; therefore, overcoming the resistance pattern seen with other anthracycline compounds.

Annamycin Basic Attributes

640.372

640.37

SNU299M83Q

C2632

Characteristics

191

0.43980

1.94g/cm3

822.1ºC at 760 mmHg

451ºC

1.763

Safety Information

P201, P202, P281, P308+P313, P405, P501

H340

|Danger|H340 (100%): May cause genetic defects [Danger Germ cell mutagenicity]|P201, P202, P281, P308+P313, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

Investigated for use/treatment in breast cancer and leukemia (unspecified).

Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)

Annamycin belongs to the anthracycline class of drugs, and has a pleiotropic mechanism of action where it targets topoisomerase II, causing strand breaks in DNA. Annamycin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.

2'-iodo-3'-hydroxy-4'-epi-4-demethoxydoxorubicin

Computed Properties

Molecular Weight:640.4
XLogP3:2.2
Hydrogen Bond Donor Count:6
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:4
Exact Mass:640.04416
Monoisotopic Mass:640.04416
Topological Polar Surface Area:191
Heavy Atom Count:38
Complexity:962
Defined Atom Stereocenter Count:7
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.